Singapore Flyer Expands 'Pre-Flight' Experience with Epson Projection Technology

The Singapore Flyer has launched an updated version of its Time Capsule attraction, allowing visitors to explore Singapore's history and extending the overall experience to over 75 minutes. The refresh, which reopened in August 2025, integrates large-scale projection, interactive storytelling, and spatial audio to create a multi-sensory prelude to the observation wheel ride.

Singapore Flyer's Time Capsule Experience

The installation employs 60 Epson 3LCD projectors across two levels and 10 themed zones. Surfaces including walls, floors, and ceilings are transformed into dynamic canvases, with projection mapping and ultra-short-throw lenses enabling visuals in challenging spaces such as mirrored rooms. The system features models like the Epson EB-PU2213B, which is ultra‑lightweight and designed to deliver high brightness and uniform imagery.

Singapore Flyer's Time Capsule Showcases Singapore's Historical Milestones

The project was developed by Untitled Project in collaboration with Singapore Flyer and local historians. The design combines motion-responsive content, AI-driven visuals, and interactive games, supported by Epson’s projection systems. Directional audio and spatial soundscapes further enhance immersion, while a companion web platform extends the experience beyond the venue.

Instagram Worthy and Trippy Showcase at the Singapore Flyer

Singapore Flyer representatives noted that visitors are spending longer within the attraction since the refresh, suggesting strong engagement from both local and international audiences. Epson Singapore described the installation as a demonstration of how projection technology can support destination experiences by combining content and design with reliable visual systems.

The Singapore Flyer, operated by Straco Corporation Limited, remains one of Singapore’s most prominent landmarks, offering panoramic views of Marina Bay and the city skyline.

Gucci Owner Kering Eyes Luxury Smart Glasses with Google

Kering, the owner of Gucci, aims to launch luxury smart glasses under the Gucci brand. This initiative will be a partnership with Google, targeting a launch in 2027.

Credit: GLA

The move could position Gucci as the first major luxury brand to enter the AI-powered eyewear sector. It would create competition for Italian-French eyewear leader EssilorLuxottica, which already produces Ray-Ban smart glasses in collaboration with Meta.

Chief Executive Officer Luca de Meo discussed the timeline at Kering’s capital markets day in Florence. The strategy is part of a broader effort to expand Kering’s eyewear and jewellery divisions.

These divisions currently account for a small fraction of the group's overall revenues. Scaling them up aims to protect the luxury company from shifts in fashion tastes, which have impacted its star brand, Gucci.

Mr. de Meo also stated an objective to more than double Kering’s operating profit margin. This would place the group among other major luxury players and aid in the revitalisation of Gucci following years of declining sales.

He further indicated that the Italian brand needs to focus on its most identifiable classics. Mr. de Meo observed that throughout Gucci's 105-year history, certain aesthetic codes are immediately recognisable, but these have at times been underutilised or overused.

Addressing the impact of geopolitical events, Mr. de Meo noted that the Middle East conflict has affected luxury sales in the Gulf and restricted travel. He underscored the necessity for large corporations to adjust to a more fragmented world.

He elaborated that businesses must improve how they sell products across different markets. He believes the traditional model of a luxury brand imposing the same concept globally, from Australia to Alaska, may not remain relevant in the coming decades.

---

• Kering plans to launch luxury smart glasses under its Gucci brand, in partnership with Google, in 2027.

• This initiative positions Gucci to become a pioneering major luxury brand in the AI-powered eyewear sector.

• Chief Executive Officer Luca de Meo views the expansion of eyewear and jewellery as key to Kering's strategic growth.

Source: REUTERS

OpenAI Unveils GPT-Rosalind AI Model for Life Sciences Research

OpenAI on Thursday introduced GPT-Rosalind, an artificial intelligence model designed to enhance biology knowledge and scientific research capabilities. This launch deepens the organisation’s push into the life sciences field.

Credit OpenAI

The GPT-Rosalind model is named after 20th-century British scientist Rosalind Franklin. It aims to support research across biochemistry, drug discovery, and translational medicine.

Demand for AI-powered tools to accelerate drug discovery and research has grown among pharmaceutical companies, academic institutions, and biotech firms.

The model is designed to help researchers accelerate the early stages of discovery, supporting evidence synthesis, hypothesis generation, experimental planning, and other multi-step research tasks.

Researchers using the model will be able to query databases, read the latest scientific papers, use other scientific tools, and suggest new experiments. GPT-Rosalind was built on OpenAI’s newest internal models.

GPT-Rosalind is available as a research preview within ChatGPT, Codex, and the application programming interface for qualified customers. This access is managed through OpenAI’s trusted access deployment structure.

OpenAI is also launching a free Life Sciences research plugin for Codex, which connects scientists to over 50 scientific tools and data sources.

The company is collaborating with customers such as Amgen, Moderna, and Thermo Fisher Scientific, among others, to apply GPT-Rosalind across various workflows.

Separately, OpenAI on Tuesday unveiled GPT-5.4-Cyber, a variant of its latest flagship model. This model is fine-tuned specifically for defensive cybersecurity work, following rival Anthropic’s introduction of its frontier AI model, Mythos.

---

• OpenAI launched GPT-Rosalind, an AI model for life sciences research.

• Named after British scientist Rosalind Franklin, it supports biochemistry, drug discovery, and translational medicine.

• The model assists researchers with tasks including evidence synthesis, hypothesis generation, and experimental planning.

Source: REUTERS